Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Flavanols are a class of polyphenolic compounds found in foods such as cocoa, tea, berries, and certain fruits. There is a growing body of scientific evidence that suggests flavanol mixtures may offer some benefit in the management of non-alcoholic fatty liver disease (NAFLD), although the evidence is still preliminary. Several animal and small human clinical studies have explored the antioxidant, anti-inflammatory, and insulin-sensitizing properties of flavanols, which could theoretically address some of the pathophysiological mechanisms underlying fatty liver disease.

For instance, certain studies have demonstrated that supplementation with flavanol-rich cocoa or green tea extracts can reduce hepatic fat accumulation and markers of liver injury in animal models of fatty liver. Limited human trials, such as those using green tea catechins (a type of flavanol), have reported modest improvements in liver enzyme levels, hepatic fat content, and inflammatory markers. However, most of these studies are small, short-term, and often use mixed interventions or extracts rather than purified flavanol compounds, making it difficult to isolate the effects of flavanols themselves. Systematic reviews and meta-analyses to date conclude that while there is potential, the current quality of evidence is low to moderate, and larger, well-designed trials are necessary to confirm efficacy and safety.

In summary, flavanol mixtures have some preliminary scientific backing for supporting fatty liver disease, but robust clinical evidence is lacking. Their use should be considered experimental until further research is available.

More about Flavanol (mixture)
More about Fatty Liver Disease

Other ingredients used for Fatty Liver Disease

Other health conditions supported by Flavanol (mixture)

Products containing Flavanol (mixture)